New shot aims to tame unruly lupus
NCT ID NCT07447986
Summary
This study is testing whether a new injectable drug called SG301 can help control the symptoms and disease activity of systemic lupus erythematosus (SLE). It will involve about 120 adults with moderate-to-severe lupus who haven't responded well to standard treatments. Participants will be randomly assigned to receive either the real drug or a placebo (dummy) injection to see if SG301 is safe and effective.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking University People's Hospital
Beijing, Beijing Municipality, China
Contact Phone: •••-•••-••••
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.